Delivery Order SPE2DB22D2108-SPE2DB24FU3BU
Award Date
1/12/24
Potential Completion Date
1/16/24
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $10,717.42 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $9,286.57, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 21, 2025. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 16, 2024, with a ceiling value of $4,433.73 and a completion date of December 17, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $6,674.81 and a completion date of December 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. The contract...
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,518.23 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999...
This federal contract award is for the delivery of Glimepiride 4 mg tablets to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, which is a leading global pharmaceutical distribution company. The award is a firm fixed price delivery order with a ceiling value of $2,223.48 and an ultimate completion date of March 27, 2024. No set-aside designation was used for this contract....
This federal contract award is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a generic prescription drug, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $4,218.99. The contract has an ultimate completion date of April 3, 2025 and was awarded on April 2, 2025. This contract is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award, valued at $2,960.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a medication used in the management of diabetes. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $3,391.54, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is a delivery order for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a generic pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and utilizes a firm fixed price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,451.03 firm fixed price delivery order is for the supply of 4564000979 - GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2024 and does not have any set-aside designation....